[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369104-105":59,"doc-detail-369104-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sugt1-is-a-prognostic-biomarker-and-is-associated-with-immune-infiltrates-in-ovarian-cancer","SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer","","Ovarian cancer remains a gynecological malignancy with poor outcomes. This study evaluates whether SGT1 (SUGT1), a protein interacting with Hsp90 and involved in cell-cycle transitions, can act as a prognostic biomarker and relate to immune infiltration. Bioinformatics analysis across TCGA and GTEx, enrichment workflows, and survival modeling were performed, followed by experimental immunohistochemistry validation. Results link elevated SUGT1 with adverse survival and specific immune-cell abundance patterns.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sugt1-is-a-prognostic-biomarker-and-is-associated-with-immune-infiltrates-in-ovarian-cancer/369104/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sugt1-is-a-prognostic-biomarker-and-is-associated-with-immune-infiltrates-in-ovarian-cancer/369104.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does SUGT1 play in ovarian cancer according to the study?","Question",{"text":112,"@type":113},"SUGT1 is overexpressed in ovarian cancer and is associated with worse overall survival, disease-specific survival, and progression-free interval. It is also identified as an independent risk factor in Cox regression analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SUGT1 expression and immune infiltration relationship analyzed?",{"text":117,"@type":113},"The study used bioinformatics analyses of SUGT1 expression in ovarian cancer versus normal controls, including GO, KEGG, GSEA, and ssGSEA. ssGSEA assessed correlations between SUGT1 levels and immune-cell abundance.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental validation was performed?",{"text":121,"@type":113},"The expression of SUGT1 in ovarian cancer and normal tissues was validated using immunohistochemistry.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369104,1790252083,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Ge etal. European Journal  \nEuropean Journal of Medical Research (2025) 30:21  \n[https://doi.org/10.1186/s40001-024-02232-5](https://doi.org/10.1186/s40001-024-02232-5 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-024-02232-5 of Medical Research)  \n RESEARCH Open Access  \nSUGT1 is a prognostic biomarker and is associated with immune infiltratesin ovarian cancer  \nLinyan Ge1†, Xiu Liu1,2†, Lingyan Zhang1, Jiaren Zhang1,2 and Guanghui Song1,2*  \nAbstract  \nBackground Ovarian cancer (OC) is a prevalent gynecological malignancy with a relatively dismal prognosis. The SGT1 homolog (SUGT1) protein, which interacts with heat shock protein 90 and is essential for the G1/S and G2/M transitions, was formerly thought to be a cancer promoter, but its precise role in OC remains unknown.  \nMethods We conducted a comprehensive bioinformatics analysis of SUGT1 expression in patients with OC compared with their normal controls, including the data from the cancer genome atlas (TCGA), genotype–tissue expression (GTEx) databases, gene ontology (GO) analysis, Kyoto Encylopedia of Genes and Genomes (KEGG) analysis, gene set enrichment analysis (GSEA), single sample gene set enrichment analysis (ssGSEA) . In addition, Kaplan–Meier (KM) analysis, univariate and multivariate Cox analyses were applied to investigate the prognostic role of SUGT1 in ovarian cancer. Furthermore, we validated the expression of SUGT1 in OC and normal tissues through immunohistochemistry. Results SUGT1 was significantly overexpressed in OC than in normal tissues. In addition, the GO, KEGG and GSEA analysis revealed that SUGT1 was associated with the functions related to immunoglobulin complex, antigen binding, immunoglobulin receptor binding, among others. Besides, ssGSEA demonstrated a positive correlation between SUGT1 expression and the abundance ofT central memory cells, natural killer cells, and T gamma delta cells, although it showed a negative association with activated dendritic cells, cytotoxic cells, T cells, and T helper 1 cells. Subsequently, KM survival analysis revealed that high SUGT1 expression indicated a shorter overall survival, disease specific survival and progression free interval in OC patients. Univariate and multivariate Cox regression revealed that SUGT1 could serve as an independent risk factor for prognosis of patients with OC.  \nConclusions All these results of this study show that SUGT1 is an important molecular component in immune infiltration in OC and may have a new significant prognostic role in OC.  \nKeywords Ovarian cancer, SUGT1, Prognosis, Immune infiltration, Biomarker  \n†\\#These authors have contributed equally to this work and authors declare no conflicts of interest.  \n*Correspondence: Guanghui Song [songgh@zju.edu.cn](songgh@zju.edu.cn)  \nFull list of author information is available at the end of the article  \nIntroduction  \nWorldwide, ovarian cancer (OC) is the fifth most deadly type of cancer in women. It is a prevalent cancer of the female reproductive system [1]. Every year, over 300,000 women are infected by OC, and around 152,000 women die as a result of this disease. The incidence rate is 3.4%, with a 4.7% fatality rate [2]. This sobering statistic underscores the grave threat that ovarian cancer poses to women’s health and survival.  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicat","cbCaifGHUA60bZV6","https://ap.wps.com/l/cbCaifGHUA60bZV6","pdf",4192569,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What role does SUGT1 play in ovarian cancer according to the study?\",\"answer\":\"SUGT1 is overexpressed in ovarian cancer and is associated with worse overall survival, disease-specific survival, and progression-free interval. It is also identified as an independent risk factor in Cox regression analyses.\"},{\"question\":\"How was SUGT1 expression and immune infiltration relationship analyzed?\",\"answer\":\"The study used bioinformatics analyses of SUGT1 expression in ovarian cancer versus normal controls, including GO, KEGG, GSEA, and ssGSEA. ssGSEA assessed correlations between SUGT1 levels and immune-cell abundance.\"},{\"question\":\"What experimental validation was performed?\",\"answer\":\"The expression of SUGT1 in ovarian cancer and normal tissues was validated using immunohistochemistry.\"}]","SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer | PDF",1790180763,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f1255f9f44733793bec5d00cb1d756b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5043a3e9ea6616e45962635802d27895.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63cc512c3c082811ad4a1d87681a808a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/473cf9e4eacc10972367565b66d9b5e3.webp",980,1301]